CN103705846A - Traditional Chinese medicine preparation for treating ovarian cyst - Google Patents

Traditional Chinese medicine preparation for treating ovarian cyst Download PDF

Info

Publication number
CN103705846A
CN103705846A CN201310725328.5A CN201310725328A CN103705846A CN 103705846 A CN103705846 A CN 103705846A CN 201310725328 A CN201310725328 A CN 201310725328A CN 103705846 A CN103705846 A CN 103705846A
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine preparation
rhizoma
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310725328.5A
Other languages
Chinese (zh)
Other versions
CN103705846B (en
Inventor
庞景三
肖跃红
张桂芳
赵增强
何杨
刘洪波
李梦华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanyang Medical College
Original Assignee
Nanyang Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanyang Medical College filed Critical Nanyang Medical College
Priority to CN201310725328.5A priority Critical patent/CN103705846B/en
Publication of CN103705846A publication Critical patent/CN103705846A/en
Application granted granted Critical
Publication of CN103705846B publication Critical patent/CN103705846B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a traditional Chinese medicine preparation for treating ovarian cyst. The traditional Chinese medicine preparation for treating ovarian cyst is prepared from the following raw medicines: astragalus, codonopsis pilosula, Chinese yam, rhizoma smilacis glabrae, red paeony root, cyrtomium fortunei, curcuma zedoary, pericarpium arecae, rhizoma sparganii, poria cocos, cassia twig, motherwort, dried tangerine or orange peel, fructus aurantii and liquorice. The medicines are combined with one another, so that the synergistic effect is generated among the effects of the medicines, and the effects of soothing the liver, inducing diuresis, promoting blood circulation to remove blood stasis, warming meridians and promoting coronary circulation, nourishing qi and promoting circulation and promoting blood circulation and eliminating stagnation are achieved. Therefore, the traditional Chinese medicine preparation for treating ovarian cyst accords with the principle of syndrome differentiation and treatment in traditional Chinese medicine and is supported by modern pharmacological research, so that the curative effect is obvious. Moreover, the traditional Chinese medicine preparation does not have a toxic or side effect, is stable in long-term curative effect and convenient to take and is worthy of popularization and application.

Description

The Chinese medicine preparation for the treatment of ovarian cyst
Technical field
The invention belongs to Chinese medicine technical field, be specifically related to a kind of Chinese medicine preparation for the treatment of ovarian cyst.
Background technology
Ovarian cyst is gynecological clinic common disease, accounts for 90% of ovarian tumor.Be common in women at fertile age, sickness rate accounts for 5% of women at fertile age, it is optimum that ovarian cyst mostly is, early stage many no conscious symptons, but the increase gradually along with cyst, clinically there is the diseases such as irregular, dysmenorrhea of menstruation menstrual period, cycle, affect women's healthy and fertility, caused very big misery to patient's body and mind.It is closely related that modern medicine thinks that primary disease occurs with pelvic inflammatory disease outbreak repeatedly, viral infection, endocrine disturbance etc.The problems such as for the treatment of primary disease, doctor trained in Western medicine often adopts under antibiotic infection, operative treatment or B ultrasonic localised puncture to extract capsule liquid, but has easily recurrence, and Western medicine side effect is larger, and Complications after surgical treatment is many.Chinese traditional treatment primary disease has accumulated rich experiences, satisfactory effect.The Chinese patent medicine that has on the market at present some treatment primary disease, but onset is slow mostly, uncertain therapeutic efficacy is cut and expensive.Therefore, find a kind of safe and effective, taking convenience, low-cost Chinese medicine preparation become ovarian cyst patient in the urgent need to.
Summary of the invention
For the etiology and pathology of ovarian cyst, anti-inflammation, antiallergic action, raising immunity of organisms, improve microcirculation and promote that histiocyte reparation is the pharmacological basis for the treatment of by Chinese herbs ovarian cyst.The inventor, through long-term clinical practice, research repeatedly, has found the Chinese medicine preparation (capsule ball disappears) of the treatment ovarian cyst of better efficacy finally.
Therefore, the object of the invention is to provide that a kind of side effect is little, treating both the principal and secondary aspects of a disease, can more effectively treat the Chinese medicine preparation of ovarian cyst.
For achieving the above object, the technical scheme that the present invention takes is that the Chinese medicine preparation of described treatment ovarian cyst is to be made by the former medicine of following weight portion: 20~40 parts of the Radixs Astragali, 10~20 parts of Radix Codonopsis, 10~30 parts of Rhizoma Dioscoreaes, 20~40 parts of Rhizoma Smilacis Glabraes, 10~20 parts of Radix Paeoniae Rubra, 10~20 parts of Rhizoma Osmundae, 10~20 parts of Rhizoma Curcumae, 10~20 parts of Pericarpium Arecae, 5~15 parts of Rhizoma Sparganii, 10~20 parts, Poria, 5~15 parts of Ramulus Cinnamomi, 10~30 parts of Herba Leonuris, 10~20 parts of Pericarpium Citri Reticulataes, 10~20 parts of Fructus Aurantiis, 3~9 parts, Radix Glycyrrhizae.
The medicament selection Radix Astragali of the present invention, Radix Codonopsis, Rhizoma Dioscoreae, Rhizoma Smilacis Glabrae, Radix Paeoniae Rubra, Rhizoma Osmundae, Rhizoma Curcumae, Pericarpium Arecae, Rhizoma Sparganii, Poria, Ramulus Cinnamomi, Herba Leonuri, Pericarpium Citri Reticulatae, Fructus Aurantii, Radix Glycyrrhizae combine, make each efficacy of drugs produce synergism these drug regimens, thereby be effectively total to long memorial liver, dampness removing, removing toxic substances, blood circulation promoting and blood stasis dispelling, warming the meridian and promoting blood circulation, the effect of promote the circulation of qi and water, blood circulation promoting and dispersing pathogen accumulation.
Motherland's medical science is thought, ovarian cyst genus " mass in the abdomen ", " lump in the abdomen ", " gathering " category.How, because women ignores conditioning in menstrual period or puerperal, in the heresy because of internal injury caused by excess of seven emotions or six climate exopathogens, invade, visceral dysfunction, causes in turbid damp phlegm retention rawly, and stagnation of blood stasis vessels of the uterus, accumulates and with the passing of time form cyst.Therefore primary disease pathogenesis core is: stagnation of liver-QI with deficiency of the spleen, phlegm and blood stasis.Treatment should invigorating the spleen and relieving depression of liver-QI, dampness removing reduces phlegm, the method for blood circulation promoting and dispersing pathogen accumulation.The Chinese medicine preparation for the treatment of ovarian cyst of the present invention (calling the capsule ball that disappears in the following text) is reused the Radix Astragali, Radix Codonopsis, Rhizoma Dioscoreae spleen invigorating, Pericarpium Citri Reticulatae, Fructus Aurantii is soothing the liver, Poria, Pericarpium Arecae dampness removing, Rhizoma Smilacis Glabrae, Rhizoma Osmundae removing toxic substances, Rhizoma Sparganii, Rhizoma Curcumae, Radix Paeoniae Rubra, Herba Leonuri blood circulation promoting and blood stasis dispelling, Ramulus Cinnamomi warming the meridian and promoting blood circulation, promote the circulation of qi and water, Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription.Gather altogether that invigorating the spleen and relieving depression of liver-QI, dampness removing reduce phlegm, the effect of blood circulation promoting and dispersing pathogen accumulation.Modern pharmacological research shows: the Radix Astragali, Radix Codonopsis, Rhizoma Dioscoreae, Poria can improve immunity of organisms; Rhizoma Smilacis Glabrae, Pericarpium Arecae, Rhizoma Sparganii, Rhizoma Curcumae, Rhizoma Osmundae etc. all have inhibiting bacteria and diminishing inflammation, antivirus action; Pericarpium Citri Reticulatae, Fructus Aurantii, Radix Glycyrrhizae antiallergic action; Blood-activating and stasis-removing can be improved microcirculation, reduce vascular permeability.
Visible, the Chinese medicine preparation for the treatment of ovarian cyst of the present invention had both met the principle of motherland's medical science determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs, had again modern pharmacological research support, therefore evident in efficacy; And have no side effect, late result is stable, and taking convenience, is worthy of popularization.
The specific embodiment
The Chinese medicine preparation for the treatment of ovarian cyst of the present invention is to be made by the former medicine of following weight portion: 20~40 parts of the Radixs Astragali, 10~20 parts of Radix Codonopsis, 10~30 parts of Rhizoma Dioscoreaes, 20~40 parts of Rhizoma Smilacis Glabraes, 10~20 parts of Radix Paeoniae Rubra, 10~20 parts of Rhizoma Osmundae, 10~20 parts of Rhizoma Curcumae, 10~20 parts of Pericarpium Arecae, 5~15 parts of Rhizoma Sparganii, 10~20 parts, Poria, 5~15 parts of Ramulus Cinnamomi, 10~30 parts of Herba Leonuris, 10~20 parts of Pericarpium Citri Reticulataes, 10~20 parts of Fructus Aurantiis, 3~9 parts, Radix Glycyrrhizae.
Medicine-feeding is fine flour altogether, develop as the watered pill, mono-bag of 24g, 2 times on the one, one time 1 bag.14 days courses for the treatment of.
Embodiment mono-:
The Chinese medicine preparation for the treatment of ovarian cyst of the present invention is to be made by the former medicine of following weight portion: 20 parts of the Radixs Astragali, 10 parts of Radix Codonopsis, 10 parts of Rhizoma Dioscoreaes, 20 parts of Rhizoma Smilacis Glabraes, 10 parts of Radix Paeoniae Rubra, 10 parts of Rhizoma Osmundae, 10 parts of Rhizoma Curcumae, 10 parts of Pericarpium Arecae, 5 parts of Rhizoma Sparganii, 10 parts, Poria, 5 parts of Ramulus Cinnamomi, 10 parts of Herba Leonuris, 10 parts of Pericarpium Citri Reticulataes, 10 parts of Fructus Aurantiis, 3 parts, Radix Glycyrrhizae.
Embodiment bis-:
The Chinese medicine preparation for the treatment of ovarian cyst of the present invention is to be made by the former medicine of following weight portion: 30 parts of the Radixs Astragali, 15 parts of Radix Codonopsis, 20 parts of Rhizoma Dioscoreaes, 30 parts of Rhizoma Smilacis Glabraes, 5 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma Osmundae, 15 parts of Rhizoma Curcumae, 15 parts of Pericarpium Arecae, 10 parts of Rhizoma Sparganii, 15 parts, Poria, 10 parts of Ramulus Cinnamomi, 20 parts of Herba Leonuris, 15 parts of Pericarpium Citri Reticulataes, 15 parts of Fructus Aurantiis, 6 parts, Radix Glycyrrhizae.
Embodiment tri-:
The Chinese medicine preparation for the treatment of ovarian cyst of the present invention is to be made by the former medicine of following weight portion: 40 parts of the Radixs Astragali, 20 parts of Radix Codonopsis, 30 parts of Rhizoma Dioscoreaes, 40 parts of Rhizoma Smilacis Glabraes, 20 parts of Radix Paeoniae Rubra, 20 parts of Rhizoma Osmundae, 20 parts of Rhizoma Curcumae, 20 parts of Pericarpium Arecae, 15 parts of Rhizoma Sparganii, 20 parts, Poria, 15 parts of Ramulus Cinnamomi, 30 parts of Herba Leonuris, 20 parts of Pericarpium Citri Reticulataes, 20 parts of Fructus Aurantiis, 9 parts, Radix Glycyrrhizae.
clinical observation material
(1) invention medicine major function and therapeutic domain
1, major function:
Invigorating the spleen and relieving depression of liver-QI, dampness removing reduce phlegm, blood circulation promoting and dispersing pathogen accumulation.
2, therapeutic domain:
Be applicable to ovarian cyst.
(2) clinical observation of medicine of the present invention
Treatment group Drug therapy of the present invention, matched group Guizhi Fuling Pills in Treating.Therapeutic outcome: in treatment group 151 examples, recovery from illness 45 examples, account for 29.8%; Effective 32 examples, account for 21.2%; Effective 60 examples, account for 39.7%; Invalid 14 examples, account for 9.3%; Total effective rate 90.7%.29 examples of fully recovering in matched group 143 examples, account for 20.3%; Effective 36 examples, account for 25.2%; Effective 36 examples, account for 25.2%; Invalid 42 examples, account for 29.3%; Total effective rate 70.7%.Two groups of total effective rates compare P < 0.01
Table 1 liang group curative effect comparison
The capsule ball group that disappears as can be seen from Table 1 curative effect is obviously better than Ramulus Cinnamomi Poria pill group (p < 0.01).

Claims (1)

1. treat a Chinese medicine preparation for ovarian cyst, the Chinese medicine preparation that it is characterized in that described treatment ovarian cyst is to be made by the former medicine of following weight portion: 20~40 parts of the Radixs Astragali, 10~20 parts of Radix Codonopsis, 10~30 parts of Rhizoma Dioscoreaes, 20~40 parts of Rhizoma Smilacis Glabraes, 10~20 parts of Radix Paeoniae Rubra, 10~20 parts of Rhizoma Osmundae, 10~20 parts of Rhizoma Curcumae, 10~20 parts of Pericarpium Arecae, 5~15 parts of Rhizoma Sparganii, 10~20 parts, Poria, 5~15 parts of Ramulus Cinnamomi, 10~30 parts of Herba Leonuris, 10~20 parts of Pericarpium Citri Reticulataes, 10~20 parts of Fructus Aurantiis, 3~9 parts, Radix Glycyrrhizae.
CN201310725328.5A 2013-12-25 2013-12-25 The Chinese medicine preparation for the treatment of ovarian cyst Expired - Fee Related CN103705846B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310725328.5A CN103705846B (en) 2013-12-25 2013-12-25 The Chinese medicine preparation for the treatment of ovarian cyst

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310725328.5A CN103705846B (en) 2013-12-25 2013-12-25 The Chinese medicine preparation for the treatment of ovarian cyst

Publications (2)

Publication Number Publication Date
CN103705846A true CN103705846A (en) 2014-04-09
CN103705846B CN103705846B (en) 2016-02-03

Family

ID=50399433

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310725328.5A Expired - Fee Related CN103705846B (en) 2013-12-25 2013-12-25 The Chinese medicine preparation for the treatment of ovarian cyst

Country Status (1)

Country Link
CN (1) CN103705846B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104383181A (en) * 2014-11-12 2015-03-04 安顺市西秀区钰霖种养殖农民专业合作社 Pharmaceutical composition containing paeonia lactiflora and preparation method of pharmaceutical composition
CN104587399A (en) * 2015-01-23 2015-05-06 青岛市中心医院 Traditional Chinese medicine for treating ovarian cyst
CN104815163A (en) * 2015-04-17 2015-08-05 王�琦 Traditional Chinese medicine prescription for treating ovarian cyst

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
刘军莲等: "多囊卵巢综合征经验方中医辨证概述", 《辽宁中医杂志》, vol. 40, no. 3, 31 March 2013 (2013-03-31) *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104383181A (en) * 2014-11-12 2015-03-04 安顺市西秀区钰霖种养殖农民专业合作社 Pharmaceutical composition containing paeonia lactiflora and preparation method of pharmaceutical composition
CN104587399A (en) * 2015-01-23 2015-05-06 青岛市中心医院 Traditional Chinese medicine for treating ovarian cyst
CN104815163A (en) * 2015-04-17 2015-08-05 王�琦 Traditional Chinese medicine prescription for treating ovarian cyst

Also Published As

Publication number Publication date
CN103705846B (en) 2016-02-03

Similar Documents

Publication Publication Date Title
CN102178901B (en) Medicament for treating uterus cancer
CN102940853B (en) Navel paste for treating mammary gland hyperplasia diseases
CN103316174B (en) Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof
CN104587442A (en) Foot bath traditional Chinese medicine composition for treating wind-cold-dampness arthralgia and application of foot bath traditional Chinese medicine composition
CN101711848B (en) Chinese medicinal composition capable of adjunctively treating tumour
CN103463357A (en) Medicinal liquor capable of warming and invigorating kidney yang and preparing method thereof
CN103705846B (en) The Chinese medicine preparation for the treatment of ovarian cyst
CN104491220A (en) Traditional Chinese medicine composition for treating herpes zoster
CN103845429A (en) Traditional Chinese medicine for treating chronic hepatitis
CN103341088B (en) Medicine for treating blood sugar type fatty liver
CN104257883A (en) Traditional Chinese medicine composition for treating leucopenia after chemotherapy
CN104107393A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis
CN101491612B (en) Medicine for treating mammary hyperplasia and early breast cancer
CN102349957A (en) Traditional Chinese medicine composition for treating prurigo
CN102743686B (en) The scorching clearing capsule of a kind of basin
CN102205067B (en) Traditional Chinese medicine composition for treating chronic urticaria
CN1517115A (en) Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation
CN103800664A (en) Traditional Chinese medicine composition for treating menopausal syndrome
CN103341122A (en) Traditional Chinese medicine composition for treating gallstone
CN102670878B (en) Traditional Chinese medicine decoction for treating acute mastitis
CN101972306B (en) Chinese medicinal capsule for treating chronic pelvic inflammatory disease
CN102091271A (en) Medicine for treating hyperplasia of mammary glands and preparation method thereof
CN103356965A (en) Drug for curing rheumatoid arthritis
CN102764325A (en) Chinese medicinal composition for dispelling rheumatism and relieving pain
CN103285259A (en) Traditional Chinese medicine composition for treating hyperlipidemia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information

Inventor after: Pang Jingsan

Inventor after: Li Gaifei

Inventor after: Zhang Guifang

Inventor after: Zhao Zengqiang

Inventor after: He Yang

Inventor after: Ma Jieyu

Inventor after: Li Menghua

Inventor before: Pang Jingsan

Inventor before: Xiao Yuehong

Inventor before: Zhang Guifang

Inventor before: Zhao Zengqiang

Inventor before: He Yang

Inventor before: Liu Hongbo

Inventor before: Li Menghua

COR Change of bibliographic data
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160203

Termination date: 20161225

CF01 Termination of patent right due to non-payment of annual fee